Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 23, 2025Journal of the Peripheral Nervous System

Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgM‐RODS

View Full Paper
Ask AI
Bookmark
Share

Authors

THTatiana HamadehJMJohannes P. M. van de MortelJHJanneke G. J. Hoeijmakers

Discussion

Loading...

Member takes

Overview

The research develops a Rasch-built scale for measuring disability in IgM polyneuropathy, indicating valid assessment properties.

Key Points

  • The 36-item IgM-RODS effectively detects functional deficits in patients with IgM polyneuropathy ±anti-MAG, enhancing assessment capabilities.
  • The study utilized Rasch analyses on data from 244 subjects across 8 countries, demonstrating the scale's reliability and validity.
  • Systematic item removal during testing improved the IgM-RODS, fulfilling Rasch model requirements for unidimensionality and sensitivity.
  • This disease-specific metric supports future research by providing a tailored assessment tool for IgM-polyneuropathy patients.

Cite This Study

Hamadeh et al. (2025) studied this question.

synapsesocial.com/papers/68d4757f31b076d99fa6ccb9https://doi.org/10.1111/jns.70059
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Measurement properties of the Inflammatory Rasch-built Overall Disability Scale (I-RODS) in patients with Guillain–Barré syndrome2026
  2. 2Rasch-Built Overall Disability Scale for Chronic Idiopathic Axonal Polyneuropathy2026
  3. 3Raw, centile and individualised minimal clinically important differences for the MMN-Rasch-built Overall Disability Scale© in the monitoring of multifocal motor neuropathy2026
  4. 4Improving outcome measures in late onset Pompe disease: Modified Rasch‐Built Pompe‐Specific Activity scale2024 · 2 citations
  5. 5Management and long‐term haematological and neurological outcomes of <scp>Immunoglobulin M</scp> and Waldenström's macroglobulinaemia‐related neuropathy: A single‐centre experience2026